NOT-DC-13-004: Notice of Participation of NIDCD in RFA-NS-13-013 Collaborative Research on Chronic Traumatic Encephalopathy and Delayed Effects of Traumatic Brain Injury: Neuropathology and Neuroimaging Correlation (U01)

Notice of Participation of NIDCD in RFA-NS-13-013 Collaborative Research on Chronic Traumatic Encephalopathy and Delayed Effects of Traumatic Brain Injury: Neuropathology and Neuroimaging Correlation (U01)

Notice Number: NOT-DC-13-004

Key Dates
Release Date: March 29, 2013

Related Announcements
RFA-NS-13-013

Issued by
National Institute on Deafness and Other Communication Disorders (NIDCD)

Purpose

This Notice is to inform applicants that the National Institute on Deafness and Other Communication Disorders (NIDCD) has joined the funding opportunity announcement RFA-NS-13-013, entitled "Research on Chronic Traumatic Encephalopathy and Delayed Effects of Traumatic Brain Injury: Neuropathology and Neuroimaging Correlation (U01)”, effective immediately. The mission areas of NIDCD are hearing (including tinnitus), balance, taste, smell, voice, speech, and language.

The following sections of RFA-NS-13-013 have been updated to reflect the participation of NIDCD in this FOA:

Part 1. Overview Information

Components of Participating Organizations
National Institute of Neurological Disorders and Stroke (NINDS)
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institute on Drug Abuse (NIDA)
National Institute on Deafness and Other Communication Disorders (NIDCD)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.853, 93.859, 93.213, 93.279, 93.173

Part 2. Section VII. Agency Contacts

Scientific/Research Contact(s)
Gordon B. Hughes, M.D.
Director Clinical Trials Program, Division of Scientific Programs
National Institute on Deafness and Other Communication Disorders, NIH
6120 Executive Blvd.
EPS-400C MSC 7180
Bethesda, MD 20892-7120
Telephone: (301) 496-5061
Fax: (301) 402-6251
Email: hughesg@nidcd.nih.gov

Financial/Grants Management Contact(s)
Mr. Christopher Myers
Chief Grants Management, Division of Extramural Activities
National Institute on Deafness and Other Communication Disorders, NIH
EPS-400B MSC 7180
6120 Executive Blvd.
Bethesda, MD 20892-7180
Telephone: (301) 435-0713
Fax: (301) 451-5370
Email: myersc@mail.nih.gov

All other aspects of the FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Gordon B. Hughes, M.D.
Director Clinical Trials Program, Division of Scientific Programs
National Institute on Deafness and Other Communication Disorders, NIH
6120 Executive Blvd.
EPS-400C MSC 7180
Bethesda, MD 20892-7120
Telephone: (301) 496-5061
Fax: (301) 402-6251
Email: hughesg@nidcd.nih.gov